SLXN Stock Analysis: Buy, Sell, or Hold?
SLXN - Silexion Therapeutics Corp Ordinary Shares
$4.55
-0.12 (-2.55%)
▼
5d:
-8.61%
30d:
+776.88%
90d:
+132.19%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 19, 2026
0d
Get Alerted When SLXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SLXN is 28.9% above its trading range ($3.53). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SLXN is 28.9% above its trading range ($3.53). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SLXN is currently trading at $4.55, which is considered extended relative to its 30-day fair value range of $-0.29 to $3.53.
Technical Outlook: Technically, SLXN is in a downtrend. Immediate support is located at $0.37, while resistance sits at $5.45.
Market Sentiment: SLXN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $60.00 (+1184.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLXN is in a downtrend. Immediate support is located at $0.37, while resistance sits at $5.45.
Market Sentiment: SLXN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $60.00 (+1184.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.29 -
$3.53
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+28.9% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 1184.8% below Wall St target ($60.00)
- WARNING: Recommendation downgraded due to 28.9% overvaluation
Trading Range Analysis
30-Day Trading Range
$-0.29 -
$3.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.37
Resistance Level
$5.45
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.16
Wall Street Target
$60.00
(+1184.8%)
Share & Embed Analysis
Last updated: June 08, 2026 11:39 AM ET
Data refreshes hourly during market hours. Next update: 12:39 PM
Data refreshes hourly during market hours. Next update: 12:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1023 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$82 | 59 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$295 | 53 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 58 HOLD |
